Pinnacle Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,612
Closed -$433K 753
2022
Q1
$433K Buy
+5,612
New +$433K 0.01% 590